Interleukin-13 Antagonist [EPC]: Side Effects & Safety Data for 2 Drugs
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
Interleukin-13 Antagonist [EPC] includes 2 drugs with a combined 128 adverse event reports in the FDA FAERS database. Compare their safety profiles, side effects, and outcomes below.
2
Drugs in Class
128
Combined Reports
All Interleukin-13 Antagonist [EPC] Drugs Ranked by Reports
| Drug | Brand Name | Reports | Deaths | Hosp. | Death Rate |
|---|---|---|---|---|---|
| LEBRIKIZUMAB | EBGLYSS | 78 | 1 | 27 | 1.3% |
| TRALOKINUMAB | Adbry | 50 | 1 | 20 | 2.0% |
Common Side Effects in Interleukin-13 Antagonist [EPC] Drugs
| Side Effect | Reports | Deaths |
|---|---|---|
| Treatment failure | 9 | 0 |
| Conjunctivitis | 8 | 0 |
| Asthma | 7 | 0 |
| Erythema | 6 | 0 |
| Pruritus | 6 | 0 |
| Drug ineffective | 5 | 0 |